High-quality eCOA/ePRO and eDiary data is increasingly at the core of Phase I – IV clinical trial protocols. Most filings for new drugs coming to market include Patient Reported Outcome data, and the move to decentralized (DCT) approaches puts a greater focus on engaging and retaining patients.
We leverage our unique patient-first design, combined with regulatory compliant technology, to provide the most user-friendly platform for patients, sites and sponsors.
eCOA/ePRO solutions for clinical trials
Our cloud-based ePRO/eCOA platform, APIs and workflow integrations support delivery of large-scale clinical trials across the globe. Integrating with other clinical trial technology and services, we achieve high rates of data capture compliance and participant retention.
Validated eCOA / ePRO clinical data capture
Provisioned, BYOD or hybrid device approaches
24/7 multi-lingual helpdesk
GCP & 21 CFR Part 11 compliant
Sensors & data tokenization
Mobile, Tablet & Web data capture
All languages supported
IRT, EDC & data lake integrations
Phase I – III clinical trials
Capturing Patient Reported Outcomes, whether site-based or hybrid, is critical in clinical trials. Questionnaire and visit schedules can be complex and the burden high on both patients and site staff.
From oncology to cardiovascular and from inflammatory to rare disease indications, the uMotif platform’s powerful scheduling, reminders, engagement and data capture modules support highly complex global clinical trials.
Phase IIIb and IV clinical trials
Later stage clinical trials offer opportunities for sponsors to strengthen their dataset, engage patients and broaden their reach. The uMotif platform provides solutions to capture symptoms, outcomes, eDiaries and other data, while building an engaged patient group.
Available in any language and swiftly configured for global deployment for later phase clinical trials.
Decentralized Clinical Trials
Following the Covid pandemic, sponsors are carefully considering how elements of their trials can move out of the clinic and into patients’ homes. Decentralization can deliver significant benefits, but must balance high-quality data capture with a patient-centric approach.
Our toolkit of solutions enables sponsors to decentralize, while keeping the patient motivated during the trial.
Ready for a demo?
Explore how our robust, compliant and engaging approach delivers effective clinical trials.